A critical appraisal of the recent evidence in the LAA closure field

Anchorperson: L. Räber

Spokesperson: J. E. Nielsen-Kudsk

Summary

This session critically appraises recent evidence in the left atrial appendage (LAA) closure field, focusing on landmark trials such as CHAMPION-AF and CLOSURE AF. It discusses how these findings may influence patient selection and clinical practice, offering guidance on integrating new evidence into decision-making for stroke prevention in atrial fibrillation patients.

Learning Objectives

To learn about the trial designs and results of the most impactful recent LAA closure and direct oral anticoagulants trials (CHAMPION-AF, CLOSURE AF)
To learn how this evidence may change patient selection for LAA closure
To know how to implement this new evidence in the LAA closure field into daily clinical practice

Presentations available when logged in:

Welcome and session objectives
How will CHAMPION change the landscape of LAA closure?
Is LAA closure equal to direct oral anticoagulants for stroke prevention?
How does closure atrial fibrillation impact future patient selection for LAA closure?
The future of LAA closure
Session evaluation and key learnings

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

A critical appraisal of the recent evidence in the LAA closure field

Learning Objectives

Log in or create account for free